Power Law company profile

Invivyd

Biotech & Life Sciences · Waltham, United States · Founded 2020 · IPO 2021 Unicorn

Developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses

Valuation

$1.80B

Market cap · 2026

Revenue

$25M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

14 investors on Invivyd's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Mithril

Polaris Partners

Series B+ 12 investors entered at this stage

RA Capital Management

Premji Invest

Federated Hermes

Foresite Capital

Redmile Group

Adimab

Fidelity Investments

Population Health Partners

Omega Funds

OrbiMed

ArrowMark Partners

Global footprint

Where Invivyd has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States98.9%

🇨🇦 Canada1.1%

2 countries shown

Web traffic by country

17K monthly visits
across markets

🇺🇸 United States58.8%

🇬🇧 United Kingdom39.4%

🇳🇱 Netherlands2.9%

Top 3 markets shown

Patent intelligence

$2M patent portfolio · 5 active families

Estimated portfolio value

$2M

0.10% of market cap · 43.4× smaller than top peer Arcus Biosciences ($74M)

5 active patent families

Where Invivyd innovates DiseaseConformational epitopeS AntibodyAntigen Binding FragmentVirology

Where Invivyd concentrates vs peers

Each axis is a top-10 topic across Invivyd and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Invivyd

An AI-synthesized read of the highest-engagement posts about Invivyd on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Invivyd on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles